Products

Prevention and treatment of heart failure

Cardiogenic stroke

Valvular disease

Intervention consumables

DOCS VALVE®Transcatheter aortic Valve Replacement System (in Development)

The prevalence of valve disease in China is 3.8%, about 25 million people. According to industry reports, the number of patients with aortic stenosis and aortic regurgitation in China in 2022 is about 4.65 million and 4.05 million, respectively. With the aging trend of China's population, heart valve disease will increase, if not timely standardized treatment, the mortality rate of 2 years can reach 50%, and the mortality rate of 5 years is as high as 97%.

+

More

DOCS VALVE<i>®</i>Transcatheter aortic Valve Replacement System (in Development)
< 1 >